- Home
- MTEN vs COCP Comparison
MTEN vs COCP Comparison
Compare MTEN & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTEN | COCP |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 13.5M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | MTEN | COCP |
|---|---|---|
| Price | $0.83 | $0.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 989.5K | 70.5K |
| Earning Date | 10-01-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,735,337.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.63 | N/A |
| 52 Week Low | $0.52 | $0.90 |
| 52 Week High | $26.03 | $2.67 |
Technical Indicators
Market Signals| Indicator | MTEN | COCP |
|---|---|---|
| Relative Strength Index (RSI) | 33.48 | 44.66 |
| Support Level | $0.52 | $0.95 |
| Resistance Level | $0.87 | $1.01 |
| Average True Range (ATR) | 0.17 | 0.05 |
| MACD | 0.11 | -0.00 |
| Stochastic Oscillator | 54.42 | 34.86 |
Price Performance
Historical ComparisonAbout MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).